MERCK & CO INCMERCK & CO INCMERCK & CO INC

MERCK & CO INC

No trades
See on Supercharts

Key facts today

Merck & Company, Inc. obtained a global license for LM-299, a PD-1/VEGF bispecific antibody, from LaNova Medicines, involving a significant pre-tax charge and potential milestone payments.
Analyze the impactAnalyze the impact
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪247.04 T‬CLP
4,323CLP
‪321.87 B‬CLP
‪52.80 T‬CLP
‪2.53 B‬
Beta (1Y)
0.66
Employees (FY)
‪72 K‬
Change (1Y)
‪+3 K‬ +4.35%
Revenue / Employee (1Y)
‪733.28 M‬CLP
Net income / Employee (1Y)
‪4.47 M‬CLP

About Merck & Company, Inc.


CEO
Robert M. Davis
Headquarters
Rahway
Website
Founded
1891
FIGI
BBG00YFSTJK2
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
MRK5319197
Merck & Co., Inc. 2.9% 10-DEC-2061
Yield to maturity
7.02%
Maturity date
Dec 10, 2061
MRK5002693
Merck & Co., Inc. 2.45% 24-JUN-2050
Yield to maturity
7.02%
Maturity date
Jun 24, 2050
US58933YBF1
MERCK & CO. 21/51
Yield to maturity
6.93%
Maturity date
Dec 10, 2051
US58933YBA2
MERCK & CO. 20/40
Yield to maturity
6.65%
Maturity date
Jun 24, 2040
US58933YAT2
MERCK CO. 2045
Yield to maturity
6.25%
Maturity date
Feb 10, 2045
MRK4806294
Merck & Co., Inc. 4.0% 07-MAR-2049
Yield to maturity
6.14%
Maturity date
Mar 7, 2049
MRK3900816
Merck & Co., Inc. 3.6% 15-SEP-2042
Yield to maturity
6.14%
Maturity date
Sep 15, 2042
US58933YAJ4
MERCK CO. 13/43
Yield to maturity
6.03%
Maturity date
May 18, 2043
US58933YAV7
MERCK & CO. 19/39
Yield to maturity
5.91%
Maturity date
Mar 7, 2039
MRK5584756
Merck & Co., Inc. 5.15% 17-MAY-2063
Yield to maturity
5.83%
Maturity date
May 17, 2063
MRK5584755
Merck & Co., Inc. 5.0% 17-MAY-2053
Yield to maturity
5.72%
Maturity date
May 17, 2053

Explore more bonds 

Frequently Asked Questions


The current price of MRKCL is 99,470 CLP — it hasn't changed in the past 24 hours. Watch MERCK & CO INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BCS exchange MERCK & CO INC stocks are traded under the ticker MRKCL.
MRKCL stock has fallen by −0.53% compared to the previous week, the month change is a −0.53% fall, over the last year MERCK & CO INC has showed a 7.86% increase.
We've gathered analysts' opinions on MERCK & CO INC future price: according to them, MRKCL price has a max estimate of 154,382.47 CLP and a min estimate of 99,601.59 CLP. Watch MRKCL chart and read a more detailed MERCK & CO INC stock forecast: see what analysts think of MERCK & CO INC and suggest that you do with its stocks.
MRKCL reached its all-time high on Mar 28, 2024 with the price of 130,550 CLP, and its all-time low was 53,962 CLP and was reached on May 4, 2021. View more price dynamics on MRKCL chart.
See other stocks reaching their highest and lowest prices.
MRKCL stock is 0.53% volatile and has beta coefficient of 0.66. Track MERCK & CO INC stock price on the chart and check out the list of the most volatile stocks — is MERCK & CO INC there?
Today MERCK & CO INC has the market capitalization of ‪247.04 T‬, it has increased by 0.84% over the last week.
Yes, you can track MERCK & CO INC financials in yearly and quarterly reports right on TradingView.
MERCK & CO INC is going to release the next earnings report on Feb 4, 2025. Keep track of upcoming events with our Earnings Calendar.
MRKCL earnings for the last quarter are ‪1.42 K‬ CLP per share, whereas the estimation was ‪1.34 K‬ CLP resulting in a 5.80% surprise. The estimated earnings for the next quarter are ‪1.80 K‬ CLP per share. See more details about MERCK & CO INC earnings.
MERCK & CO INC revenue for the last quarter amounts to ‪15.02 T‬ CLP, despite the estimated figure of ‪14.85 T‬ CLP. In the next quarter, revenue is expected to reach ‪15.41 T‬ CLP.
MRKCL net income for the last quarter is ‪2.85 T‬ CLP, while the quarter before that showed ‪5.15 T‬ CLP of net income which accounts for −44.74% change. Track more MERCK & CO INC financial stats to get the full picture.
Yes, MRKCL dividends are paid quarterly. The last dividend per share was 805.97 CLP. As of today, Dividend Yield (TTM)% is 3.14%. Tracking MERCK & CO INC dividends might help you take more informed decisions.
MERCK & CO INC dividend yield was 2.72% in 2023, and payout ratio reached ‪2.07 K‬%. The year before the numbers were 2.52% and 49.02% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 22, 2024, the company has ‪72.00 K‬ employees. See our rating of the largest employees — is MERCK & CO INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MERCK & CO INC EBITDA is ‪16.83 T‬ CLP, and current EBITDA margin is 11.45%. See more stats in MERCK & CO INC financial statements.
Like other stocks, MRKCL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MERCK & CO INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MERCK & CO INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MERCK & CO INC stock shows the sell signal. See more of MERCK & CO INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.